EUS-guided gastroenterostomy: a multicenter study comparing the direct and balloon-assisted techniques - 13/04/18
Abstract |
Background |
EUS-guided gastroenterostomy (EUS-GE) is a developing modality in the management of gastric outlet obstruction (GOO) with several technical approaches, including the direct and balloon-assisted techniques. The aim of this study was to compare the direct with the balloon-assisted modality while further defining the role of EUS-GE in GOO.
Methods |
This multicenter, retrospective study involved consecutive patients who underwent EUS-GE with the direct or balloon-assisted technique for GOO (January 2014 to October 2016). The primary outcome was technical success. Secondary outcomes were success (ability to tolerate at least a full fluid diet), procedure time, and rate/severity of adverse events (AEs).
Results |
A total of 74 patients (44.6% women; mean age 63.0 ± 11.7 years) underwent EUS-GE for GOO (direct gastroenterostomy, n = 52; balloon-assisted gastroenterostomy, n = 22). GOO was of malignant and benign etiology in 66.2% and 33.8% of patients, respectively. Technical success was achieved in 94.2% of the direct and 90.9% of the balloon-assisted approach (P = .63). Mean procedure time was shorter with the direct technique (35.7 ± 32.1 minutes vs 89.9 ± 33.3 minutes, P < .001). The clinical success rate was 92.3% for the direct technique and 90.9% for the balloon-assisted modality (P = 1.00), with a mean time to oral intake of 1.32 ± 2.76 days. The AE rate was 6.8% with only 1 severe AE noted. Rate of AEs, postprocedure length of stay, need for reintervention, and survival were similar between the 2 groups.
Conclusions |
EUS-GE is effective and safe in the management of GOO. The direct technique may be the preferred method given its shorter procedure time when compared with the balloon-assisted approach. Prospective trials are needed to confirm these findings.
Le texte complet de cet article est disponible en PDF.Abbreviations : AE, BAGE, DGE, EUS-GE, GOO, LAMS
Plan
| DISCLOSURE: The following authors disclosed financial relationships relevant to this publication: R. Kunda: Consultant, speaker, and medical advisory board for Boston Scientific; consultant for Omega Imaging; consultant and speaker for Olympus. C. C. Thompson: Consultant for Boston Scientific and Olympus. J. Nieto, S. Irani: Consultant for Boston Scientific. T. H. Baron: Consultant and speaker for Boston Scientific and Olympus. M. A. Khashab: Consultant and on medical advisory board for Boston Scientific and Olympus. All other authors disclosed no financial relationships relevant to this publication. |
Vol 87 - N° 5
P. 1215-1221 - mai 2018 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
